Screener
MRSH MRSH Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by MRSH in its filing.
Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.
The source filing: MRSH’s 10-Q, filed July 21, 2026.
- Filed
- Jul 21, 2026, 8:13 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000062709-26-000195
| (In millions, except share data) | (Unaudited) June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,700 | $2,687 |
| Cash and cash equivalents held in a fiduciary capacity | 12,203 | 11,473 |
| Receivables | ||
| Commissions and fees | 8,289 | 7,015 |
| Advanced premiums and claims | 86 | 67 |
| Other | 727 | 750 |
Item 1.Financial Statements.
FAQ
- What is MRSH's cash & equivalents?
- MRSH (MRSH) reported cash & equivalents of $1.7B in Q2 2026.
- How has MRSH's cash & equivalents changed year-over-year?
- MRSH's cash & equivalents increased by 1.4% year-over-year, from $1.68B to $1.7B.
- What is the long-term trend for MRSH's cash & equivalents?
- Over 5 years (2020 to 2025), MRSH's cash & equivalents has grown at a 5.2% compound annual growth rate (CAGR), from $2.09B to $2.69B.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.
Ask your AI about MRSH's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude